Pradaxa Mass Claims Lawsuit
Pradaxa users who suffered a serious bleed while taking the drug may be able to sue the drug’s manufacturer. Hundreds of lawsuits have been filed against Boehringer Ingelheim claiming that the drug puts patients at risk for irreversible bleeding in the gastrointestinal tract, brain, kidneys and other organs. According to the lawsuits, the manufacturer knew about this risk and failed to warn doctors, surgeons and other medical professionals that there is no effective way to reverse the blood thinning effects of the drug in the event of an emergency.
If you or a loved one suffered a severe bleed on Pradaxa, it's not too late to join other patients and families in seeking compensation for your losses. Find out if you are eligible for legal action by completing our free case review form today. There is no cost or obligation in filling out the form.
Individual vs. Class Action Pradaxa Lawsuits
Lawsuits involving Pradaxa will not move forward as a class action, but rather proceed in a similar manner known as a Multidistrict Litigation (MDL). Both types of legal actions involve multiple individuals who are making the same allegations against the same defendant. In the case of Pradaxa, patients who suffered severe bleeding on Pradaxa are claiming that the maker of Pradaxa, Boehringer Ingelheim, failed to properly warn them about the drug’s risk of irreversible bleeds. The main difference between these two types of claims is that, in an MDL, the plaintiff retains their own individual suit and lawyer, as well as an individual award based on evidence brought forth at their own trial. A class action, on the other hand, results in a single trial and single settlement which is equally shared among the claimants.
MDLs are most commonly used in complex pharmaceutical cases, which will often involve millions of documents gathered to serve as proof in the litigation. For Pradaxa users, all of the documented evidence will be collected at once and can be used by any plaintiff in the MDL who is looking to prove their claim. It has been reported that an MDL was selected over a class action lawsuit because it helps speed up the discovery process, an issue of particular concern for Pradaxa users, many of whom are older.
Lawsuits Move Forward
In August 2011, a panel of federal judges announced that the Pradaxa lawsuits would proceed as an MDL under the guidance of Judge David Herndon of the South District of Illinois. Over the next three months, millions of pages in documents will be introduced into the case. In a year or so, a panel of judges will choose bellwether cases, which are individual bleeding injuries that are representative of hundreds of claims, according to reports. A judge will then order bellwether trials, for typically three to five cases, to indicate a future trend in litigation surrounding the drug.
Did You or a Loved One Suffer a Bleed on Pradaxa?
If so, you may be able to join the growing litigation surrounding Pradaxa. To learn more about your potential legal options, fill out our free case evaluation form today. The attorneys working with our site believe that Boehringer Ingelheim is responsible for the losses of Pradaxa users and their loved ones because they placed an unreasonably dangerous drug without an antidote onto the market. They are looking to use their decades of experience in pharmaceutical litigation to help Pradaxa users and their loved ones seek justice and recover financial compensation.